An investigation showed that arsenic trioxide can cause B-CLL cells to die, and that it kills cancerous B cells more effectively than healthy ones, affecting mainly CLL cells from high-risk patients (del17p13, high CD38 expression or unmutated IgVH status). This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.